Role of UHRF1 in osteosarcoma metastasis
UHRF1在骨肉瘤转移中的作用
基本信息
- 批准号:10310790
- 负责人:
- 金额:$ 11.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsCell LineCell ProliferationCellsCellular StructuresClinicalDataDevelopmentEpigenetic ProcessExocytosisGenesGenetic TranscriptionGenetic studyGenetically Engineered MouseGrantHumanIn VitroIncidenceKnock-outKnockout MiceMalignant NeoplasmsMetastatic Neoplasm to the LungMetastatic OsteosarcomaMicroRNAsModelingMutationNeoplasm MetastasisNonmetastaticPHD FingerPathway interactionsPhenotypeProtein SecretionProteinsResearch ProposalsRing Finger DomainRoleStromal CellsSurvival RateTP53 geneTestingTumor Cell InvasionUbiquitinangiogenesiscancer cellchemotherapyexosomegain of functiongenetic corepressorin vivoinsightloss of functionmigrationmortalitymouse modelnovel therapeutic interventionosteosarcomaoverexpressionresponsetherapeutic targettranscriptomicstumortumor microenvironmenttumorigenesis
项目摘要
Project Summary
This Diversity Supplement application builds on a parental grant studying the genetic alterations at the RB
transcriptional corepressor 1 (RB1) gene that are associated with increased mortality, metastasis and poor
response to chemotherapy in osteosarcoma. We recently identified ubiquitin-like, containing PHD and RING
finger domains-1 (UHRF1), as a key epigenetic regulator that is upregulated in osteosarcoma. Our preliminary
studies suggest that UHRF1 overexpression results in increased cell proliferation, migration, invasion, and
metastasis. For this supplement, we propose to expand the scope of our parental grant to elucidate the
mechanisms through which UHRF1 overexpression in osteosarcoma contributes to tumor invasion and
metastasis. We propose to examine the role of UHRF1 on the interaction between cancer cells and the tumor
microenvironment through exosome alterations. Exosomes have been identified as an important factor in the
modulation of cancer and stromal cells towards induction of a metastatic phenotype. We hypothesize that UHRF1
overexpression contributes to altered exosome formation and/or exosomal cargo and this contributes to
metastasis in osteosarcoma. Overall, this research proposal will broaden our understanding of the role of UHRF1
in osteosarcoma metastasis.
项目概要
该多样性补充申请以父母资助为基础,研究 RB 的基因改变
转录辅阻遏物 1 (RB1) 基因与死亡率增加、转移和贫困有关
骨肉瘤对化疗的反应。我们最近发现了类泛素,包含 PHD 和 RING
Finger 结构域-1 (UHRF1),作为骨肉瘤中上调的关键表观遗传调节因子。我们的初步
研究表明,UHRF1 过度表达会导致细胞增殖、迁移、侵袭和迁移增加
转移。对于此补充,我们建议扩大家长补助金的范围,以阐明
UHRF1在骨肉瘤中过度表达导致肿瘤侵袭和侵袭的机制
转移。我们建议检查 UHRF1 在癌细胞与肿瘤之间相互作用中的作用
通过外泌体改变微环境。外泌体已被确定为重要因素
调节癌症和基质细胞以诱导转移表型。我们假设UHRF1
过度表达有助于改变外泌体形成和/或外泌体货物,这有助于
骨肉瘤的转移。总的来说,这项研究计划将拓宽我们对 UHRF1 作用的理解
在骨肉瘤转移中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Claudia Andrea Benavente其他文献
Claudia Andrea Benavente的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Claudia Andrea Benavente', 18)}}的其他基金
Role of UHRF1 in osteosarcoma and its relationship to RB
UHRF1在骨肉瘤中的作用及其与RB的关系
- 批准号:
10524098 - 财政年份:2019
- 资助金额:
$ 11.11万 - 项目类别:
Role of UHRF1 in osteosarcoma and its relationship to RB
UHRF1在骨肉瘤中的作用及其与RB的关系
- 批准号:
10759010 - 财政年份:2019
- 资助金额:
$ 11.11万 - 项目类别:
Role of UHRF1 in osteosarcoma and its relationship to RB
UHRF1在骨肉瘤中的作用及其与RB的关系
- 批准号:
10165665 - 财政年份:2019
- 资助金额:
$ 11.11万 - 项目类别:
Role of UHRF1 in osteosarcoma and its relationship to RB
UHRF1在骨肉瘤中的作用及其与RB的关系
- 批准号:
10404640 - 财政年份:2019
- 资助金额:
$ 11.11万 - 项目类别:
Role of UHRF1 in osteosarcoma and its relationship to RB
UHRF1在骨肉瘤中的作用及其与RB的关系
- 批准号:
10654716 - 财政年份:2019
- 资助金额:
$ 11.11万 - 项目类别:
Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma
视网膜母细胞瘤和骨肉瘤的基因组不稳定性和表观遗传失调
- 批准号:
8568283 - 财政年份:2013
- 资助金额:
$ 11.11万 - 项目类别:
Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma
视网膜母细胞瘤和骨肉瘤的基因组不稳定性和表观遗传失调
- 批准号:
8734350 - 财政年份:2013
- 资助金额:
$ 11.11万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 11.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 11.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 11.11万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 11.11万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 11.11万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 11.11万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 11.11万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 11.11万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 11.11万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 11.11万 - 项目类别:
Studentship